Cargando…
Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?
Bisphosphonates are commonly used in the treatment of osteoporosis. Atypical femoral fracture (AFF) is a well-known adverse effect of bisphosphonate use. The importance of genetic factors has been demonstrated in bone quality, bone turnover, and in the response to osteoporosis treatment. Herein, we...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bayçınar Medical Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606994/ https://www.ncbi.nlm.nih.gov/pubmed/34870126 http://dx.doi.org/10.5606/tftrd.2021.5248 |
_version_ | 1784602457389662208 |
---|---|
author | Okçu, Mehmet Aybala Koçak, Fatmanur Sancar Kaya, Samet Tuncay, Figen |
author_facet | Okçu, Mehmet Aybala Koçak, Fatmanur Sancar Kaya, Samet Tuncay, Figen |
author_sort | Okçu, Mehmet |
collection | PubMed |
description | Bisphosphonates are commonly used in the treatment of osteoporosis. Atypical femoral fracture (AFF) is a well-known adverse effect of bisphosphonate use. The importance of genetic factors has been demonstrated in bone quality, bone turnover, and in the response to osteoporosis treatment. Herein, we present two cases of bilateral AFFs after bisphosphonate use for a short period of time in members of the same family (mother and her daughter) and discuss genetic predisposition to bisphosphonate-induced AFFs in the light of literature data. |
format | Online Article Text |
id | pubmed-8606994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Bayçınar Medical Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-86069942021-12-02 Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? Okçu, Mehmet Aybala Koçak, Fatmanur Sancar Kaya, Samet Tuncay, Figen Turk J Phys Med Rehabil Case Report Bisphosphonates are commonly used in the treatment of osteoporosis. Atypical femoral fracture (AFF) is a well-known adverse effect of bisphosphonate use. The importance of genetic factors has been demonstrated in bone quality, bone turnover, and in the response to osteoporosis treatment. Herein, we present two cases of bilateral AFFs after bisphosphonate use for a short period of time in members of the same family (mother and her daughter) and discuss genetic predisposition to bisphosphonate-induced AFFs in the light of literature data. Bayçınar Medical Publishing 2021-09-01 /pmc/articles/PMC8606994/ /pubmed/34870126 http://dx.doi.org/10.5606/tftrd.2021.5248 Text en Copyright © 2021, Turkish Society of Physical Medicine and Rehabilitation https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Report Okçu, Mehmet Aybala Koçak, Fatmanur Sancar Kaya, Samet Tuncay, Figen Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? |
title | Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? |
title_full | Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? |
title_fullStr | Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? |
title_full_unstemmed | Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? |
title_short | Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? |
title_sort | is there a familial predisposition to bisphosphonate-induced atypical femoral fractures? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606994/ https://www.ncbi.nlm.nih.gov/pubmed/34870126 http://dx.doi.org/10.5606/tftrd.2021.5248 |
work_keys_str_mv | AT okcumehmet isthereafamilialpredispositiontobisphosphonateinducedatypicalfemoralfractures AT aybalakocakfatmanur isthereafamilialpredispositiontobisphosphonateinducedatypicalfemoralfractures AT sancarkayasamet isthereafamilialpredispositiontobisphosphonateinducedatypicalfemoralfractures AT tuncayfigen isthereafamilialpredispositiontobisphosphonateinducedatypicalfemoralfractures |